Antioxidant activity and structural modifications of serum chondroitin sulfate in Graves' disease

The structural modifications of serum CS in Graves' patients clinically free of ocular complications are probably the expression of systemic connective tissue remodelling. Simultaneously, these modifications may participate in a defence response to free radical damage underlying this pathology.